SI
SI
discoversearch

Biotech / Medical : MGNX -- MacroGenics
MGNX 19.20+5.6%Nov 17 8:10 PM ESTNews

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (47)8/3/2017 2:15:20 PM
From: tuck  Read Replies (1) of 76
 
The point is to do this ahead of P1 results (early), from competitive landscape and in-house toxicology/efficacy model.
This would be ideal, sure, but interspecies (cynomolgus monkey vs human) differences in target antigen density may not be well known in all cases, making early calls like this problematic? To say nothing of inter patient differences in antigen density in tumors.


Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

Copyright © 1995-2017 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.